Cargando…
Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes
In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111619/ https://www.ncbi.nlm.nih.gov/pubmed/27741426 http://dx.doi.org/10.1016/j.virol.2016.09.006 |
_version_ | 1783513319720615936 |
---|---|
author | Lülf, Anna-Theresa Freudenstein, Astrid Marr, Lisa Sutter, Gerd Volz, Asisa |
author_facet | Lülf, Anna-Theresa Freudenstein, Astrid Marr, Lisa Sutter, Gerd Volz, Asisa |
author_sort | Lülf, Anna-Theresa |
collection | PubMed |
description | In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in fully permissive cell cultures. To evaluate the biological activity of the non-plaque-forming particles, we generated recombinant viruses expressing fluorescent reporter proteins under transcriptional control of specific viral early and late promoters. Live cell imaging and automated counting by fluorescent microscopy indicated that virtually all virus particles can enter cells and switch on viral gene expression. Although most of the non-plaque-forming infections are arrested at the level of viral early gene expression, we detected activation of late viral transcription in 10–20% of single infected cells. Thus, non-plaque-forming particles are biologically active, and likely contribute to the immunogenicity of vaccinia virus vaccines. |
format | Online Article Text |
id | pubmed-7111619 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71116192020-04-02 Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes Lülf, Anna-Theresa Freudenstein, Astrid Marr, Lisa Sutter, Gerd Volz, Asisa Virology Article In cell culture infections with vaccinia virus the number of counted virus particles is substantially higher than the number of plaques obtained by titration. We found that standard vaccine preparations of recombinant Modified Vaccinia virus Ankara produce only about 20–30% plaque-forming virions in fully permissive cell cultures. To evaluate the biological activity of the non-plaque-forming particles, we generated recombinant viruses expressing fluorescent reporter proteins under transcriptional control of specific viral early and late promoters. Live cell imaging and automated counting by fluorescent microscopy indicated that virtually all virus particles can enter cells and switch on viral gene expression. Although most of the non-plaque-forming infections are arrested at the level of viral early gene expression, we detected activation of late viral transcription in 10–20% of single infected cells. Thus, non-plaque-forming particles are biologically active, and likely contribute to the immunogenicity of vaccinia virus vaccines. Elsevier Inc. 2016-12 2016-10-11 /pmc/articles/PMC7111619/ /pubmed/27741426 http://dx.doi.org/10.1016/j.virol.2016.09.006 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Lülf, Anna-Theresa Freudenstein, Astrid Marr, Lisa Sutter, Gerd Volz, Asisa Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title | Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title_full | Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title_fullStr | Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title_full_unstemmed | Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title_short | Non-plaque-forming virions of Modified Vaccinia virus Ankara express viral genes |
title_sort | non-plaque-forming virions of modified vaccinia virus ankara express viral genes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111619/ https://www.ncbi.nlm.nih.gov/pubmed/27741426 http://dx.doi.org/10.1016/j.virol.2016.09.006 |
work_keys_str_mv | AT lulfannatheresa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes AT freudensteinastrid nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes AT marrlisa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes AT suttergerd nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes AT volzasisa nonplaqueformingvirionsofmodifiedvacciniavirusankaraexpressviralgenes |